BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24742611)

  • 1. Peripheral neuropathy during infliximab therapy for rheumatoid arthritis.
    El Aidli S; Gaïes E; Cherif F; Zaiem A; Daghfous R; Lakhal M
    Presse Med; 2014 Sep; 43(9):1012-4. PubMed ID: 24742611
    [No Abstract]   [Full Text] [Related]  

  • 2. Multifocal motor neuropathy during treatment with infliximab.
    Cocito D; Bergamasco B; Tavella A; Poglio F; Paolasso I; Costa P; Ciaramitaro P; Isoardo G
    J Peripher Nerv Syst; 2005 Dec; 10(4):386-7. PubMed ID: 16279990
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurological complications of infliximab.
    Jarand J; Zochodne DW; Martin LO; Voll C
    J Rheumatol; 2006 May; 33(5):1018-20. PubMed ID: 16511935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrosing alveolitis after treatement of rheumatoid arthritis by infliximab].
    Nouijai A; Mounach A; Ghozlani I; Achemlal L; Bezza A; El Maghraoui A
    Presse Med; 2009 Oct; 38(10):e17-20. PubMed ID: 19447578
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis.
    Marchesoni A; Sarzi Puttini P; Gorla R; Caporali R; Arnoldi C; Atzeni F; Vianelli M; Pallavicini FB
    Clin Exp Rheumatol; 2005; 23(6):916-7. PubMed ID: 16396721
    [No Abstract]   [Full Text] [Related]  

  • 6. Reactions to infliximab in patients with rheumatoid arthritis.
    Sakellariou GT; Chatzigiannis I
    J Rheumatol; 2005 Jul; 32(7):1411-2. PubMed ID: 15996088
    [No Abstract]   [Full Text] [Related]  

  • 7. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
    Toki H; Momohara S; Tsukahara S; Ikari K
    J Rheumatol; 2008 Sep; 35(9):1896-7; author reply 1897. PubMed ID: 18785300
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative efficacy of infliximab and adalimumab in patients with rheumatoid arthritis].
    Tiurin VP; Mezenova TV; Iutrina TO; Usacheva IuV
    Klin Med (Mosk); 2013; 91(7):55-60. PubMed ID: 24437172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New therapies in rheumatoid arthritis. Stopping joint deterioration].
    Rautenstrauch J
    MMW Fortschr Med; 2000 Jan; 142(3):4-8. PubMed ID: 10726453
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infliximab for therapy of rheumatoid arthritis].
    Amano K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():517-20. PubMed ID: 15799410
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.
    Tektonidou MG; Serelis J; Skopouli FN
    Clin Rheumatol; 2007 Feb; 26(2):258-60. PubMed ID: 16683176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyositis associated with infliximab treatment for rheumatoid arthritis.
    Urata Y; Wakai Y; Kowatari K; Nitobe T; Mizushima Y
    Mod Rheumatol; 2006; 16(6):410-1. PubMed ID: 17165006
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab induced lupus in patients with rheumatoid arthritis.
    Elkayam O; Caspi D
    Clin Exp Rheumatol; 2004; 22(4):502-3. PubMed ID: 15301255
    [No Abstract]   [Full Text] [Related]  

  • 14. Retention rates of infliximab and tocilizumab during a 3-year period in a Brazilian hospital.
    Golmia RP; Scheinberg MA
    Einstein (Sao Paulo); 2013 Dec; 11(4):492-4. PubMed ID: 24488390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
    D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
    Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy.
    Rodriguez-Escalera C; Belzunegui J; Lopez-Dominguez L; Gonzalez C; Figueroa M
    Rheumatology (Oxford); 2005 Jan; 44(1):132-3. PubMed ID: 15611308
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab and brucellosis: not the usual suspects, this time.
    Akgul O; Ozgocmen S
    Mod Rheumatol; 2011 Jun; 21(3):313-5. PubMed ID: 21243400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demyelinating polyneuropathy after long-term treatment with infliximab.
    Nakamura K; Hamaguchi T; Yamada M
    Int J Rheum Dis; 2017 Nov; 20(11):1781-1782. PubMed ID: 26179198
    [No Abstract]   [Full Text] [Related]  

  • 19. [Infliximab in rheumatoid arthritis-use in a third level hospital].
    Ruano Camps R; Ordóñez Martí-Aguilar MV; Gallego Fernández C; Coret Cagigal V; Muñoz Castillo IM
    Farm Hosp; 2005 Mar; 29(2):113-8. PubMed ID: 16013933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral anterior toxic optic neuropathy and the use of infliximab.
    ten Tusscher MP; Jacobs PJ; Busch MJ; de Graaf L; Diemont WL
    BMJ; 2003 Mar; 326(7389):579. PubMed ID: 12637403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.